Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute on Drug Abuse (NIDA) is seeking to establish a Specialized Center through a U54 cooperative agreement to advance the development of pharmacotherapeutics for substance use disorders (SUD). The primary objective of the Center is to educate and mentor academic researchers in formal product development while providing technical and financial support to advance promising preclinical concepts. The Center will operate through four primary functional areas: an Administrative Core, an Outreach and Networking Core to recruit researchers and mentors, a Drug Development Training and Education Core to deliver a customized curriculum on the drug development process, and a Preclinical Study Support Core to manage sub-awards for initial experiments. NIDA intends to commit 3 million dollars to fund one award in Fiscal Year 2027. Applications will be evaluated based on scientific and technical merit through the NIH peer review system, with a focus on the collective expertise of the investigative team and the potential for the project to exert a sustained influence on the research field. Eligible applicants include for-profit organizations, including small businesses, and other institutional entities with the capacity to support such a center. Awardees must comply with NIH guidelines for preclinical studies, federal regulations for the protection of human research participants, and specific cybersecurity incident reporting requirements, including notifying HHS agencies within 48 hours of a discovery.

General Info

NIDA plans Center to support SUD pharmacotherapeutics research with training, funding, and infrastructure.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA

Full Description

Show more

The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support. Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments.

Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Call 03 M-DASH - Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II)
Solicitation # FA238426SB007
The Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II) project, specifically the Multi-Decision Advantage Sprint for Human-Machine Teaming (M-DASH), is a research effort led by the Air Force Research Laboratory. The program aims to develop Human-Machine Teaming concepts and AI/automation capabilities to provide Battle Managers with decision advantage within the Combined Joint All-Domain Command and Control (CJADC2) framework. The effort focuses on the Transformational Model for Decision Advantage (TM-DA) to bridge the gap between operational concepts and software design, specifically requiring solutions that address three decision services: PAE, MEF, and GBC. The M-DASH event is a two-week simulation sprint scheduled for January 25 to February 5, 2027, in Las Vegas, Nevada. The government anticipates awarding Firm Fixed Price contracts or Other Transaction agreements with a maximum value of 100,000 dollars per selected offeror, out of a total estimated program cost of 600,000 dollars. Payment is issued as a single sum upon the conclusion of the event and the successful delivery of a Technical Review Presentation Package, which must include an end-of-event presentation, a technology survey, and simulated run digital audit logs. Eligibility for award requires offerors to have a CMMC Level 1 Self assessment and undergo a rigorous Science and Technology Protection risk review for all senior and key personnel. Proposals were due by October 21, 2026, and were subject to strict page limits for both the proposal and the Statement of Work. All deliverables must be submitted electronically to a government-controlled repository, and contractors must comply with AFRL supplemental requirements regarding patent rights, CUI marking, and security risk disclosures.
FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 541715
New
Federal
R--AREMP AND WATER SAMPLE ANALYSIS
Solicitation # 140L4326Q0124
Solicitation 140L4326Q0124, issued by the Bureau of Land Management Oregon State Office, seeks a firm fixed-price commercial service contract for the analysis of 165 water samples for the AREMP Program. The scope of work requires the analysis of Total Nitrogen and Total Phosphorus using alkaline persulfate digestion methods, specifically adhering to Lachat QuikChem and EPA standards. The period of performance is scheduled from October 31, 2026, to March 31, 2027, with a required laboratory turnaround time of 60 days from the receipt of samples. This acquisition is set aside for Women-Owned Small Businesses, Economically Disadvantaged Women-Owned Small Businesses, and 8(a) participants under NAICS code 541715. The government will award the contract to the responsible offeror determined to be most advantageous based on price and past performance. Quotations must be submitted in two parts, consisting of a price section and a non-price section that includes details on three similar projects completed as a prime contractor within the last three years. Technical requirements are stringent, necessitating a QAPP-style validation plan, specific Method Detection Limit studies per 40 CFR 136.6, and an ongoing quality control plan. Payment will be processed electronically through the Invoice Processing Platform System. Multiple amendments have been issued to clarify analytical methods, update the NAICS code, and extend the quotation deadline to October 21, 2026.
Oregon State Office

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

24 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS